|[September 10, 2012]
Outcomes Measurement Leader launches QOLIX®, First-of-Its-Kind Quality of Life Measurement System
WORCESTER, Mass. --(Business Wire)--
John Ware Research Group, Inc.,(JWRG), a leading health outcomes
company, announces the launch of QOLIX, a patent pending Quality of Life
Measurement Information System, a new, web-based patient-centered
measurement application which improves patient outcomes measurement and
makes them more usable in patient-centered care, outcomes monitoring,
clinical trials, patient registries, predictive outcomes, and population
QOLIX is the field's first patient reported outcomes (PRO) system to
offer integrated generic and disease-specific assessments developed and
evaluated together to provide more information about a patient's
condition resulting in improved interpretation.
"We are pleased to be advancing the PRO field with the introduction of
QOLIX. It offers 'one-stop shopping' for the Researcher/Clinician who
needs a brief but accurate patient assessment, real-time norm-based
scoring, and clinical reports to provide support for clinical decision
making, comparative effectiveness research, and evidence for clinical
trials," said John E. Ware, Jr., PhD,JWRG's Founder and Chief Science
Officer and globally recognized inventor of the PRO field.
On average, a 50% reduction in respondent burden is achieved in
comparison to static forms still used today by applying a new Adaptive
Survey Logic™, (ASLX®) process and CAT, a proven adaptive
testing methodology which tailors questions administered based upon a
QOLIX is a feature rich, always-on SaaS (News - Alert) application designed in response
to clinician and researcher feedback coupled with breakthroughs in
outcomes measurement science and current technology. Its dashboard
allows sponsors control from pre-study design customization through
real-time data exports. QOLIX's API allows integration with EHRs, other
clinical records, clinical trials, or other PRO systems.
"Offering more choices to sponsors significantly reduces research costs.
With QOLIX's library of 35 conditions, sponsors have alternatives to
developing costly disease-specific PRO's or hiring third-party vendors
to program paper surveys. They can access a scientifically-valid system
offering great flexibility, thanks to technological advances in the
application," said Rosemarie Boulanger, JWRG's President.
PRO's are used in clinical trials for seeking FDA approval for label
claims for certain drugs or medical devices regarding quality of life
improvements. Clinicians use PRO's as clinical support tools for a
variety of conditions.
The QOLIX system is available only for scholarly research studies in the
U.S and available for all purposes elsewhere.
Information about QOLIX: qolix.com
; JWRG's corporate website: jwrginc.com
[ Back To TMCnet.com's Homepage ]